Shawn Tomasello, MBA

Shawn Tomasello, MBA

DirectoratCabaletta Bio· In proxies 2023–2025

Shawn Tomasello, MBA sits on 15 public boards.

Boards1

  • Cabaletta BioDirector · 1 yr on the boardIndependentCompensation, Science and Technology—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Cabaletta BioPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -80%
  2. 4D Molecular Therapeutics Inc.Public company · 6 yr
    • Director2020 – Present · 6 yrNo stock prices for these years
  3. Centrexion Therapeutics Corp.Public company · 9 yr
    • Director2017 – Present · 9 yrNo stock prices for these years
  4. Axial Biotherapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. Forte Biosciences, Inc.Public company
    • Director? – PresentNo stock prices for these years
  6. Jasper Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  7. Trishula Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  8. Clementia PharmaceuticalsPublic company
    • Director? – PresentNo stock prices for these years
  9. AlloVir, Inc.Public company
    • Director? – 2025No stock prices for these years
  10. Gamida Cell Ltd.Public company
    • Director? – 2024No stock prices for these years
  11. TCR2 Therapeutics Inc.Public company
    • Director? – 2023No stock prices for these years
  12. Mesoblast, Ltd.Public company
    • Director? – 2022No stock prices for these years
  13. Urogen Pharma LtdPublic company
    • Director? – 2022No stock prices for these years
  14. Abeona TherapeuticsPublic company
    • Director? – 2020No stock prices for these years
  15. Diplomat Pharmacy, Inc.Public company
    • Director? – 2020No stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?